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Observations on Uric Acid Transport in Man,
the Dalmatian and the non-Dalmatian Dog*
Howard Duncan, M.D.** and April S. Curtiss, B.S.**

The urinary output of uric acid from the purebred Dalmatian is similar in
amount to that in man. Also, this breed of dog has a higher plasma uric acid
level than other dogs and, like man, this hyperuricemia is accompanied
more
frequently with renal and bladder lithiasis. AUopio-inol is effective therapy in
both man and dog. Study of the fate of uric acid in the Dalmatian shows that
the liver does not oxidize the available uric acid completely although it is
capable of doing so when liver homogenates are studied. Consequently, the hepatic
cellular membrane appears impermeable, or partially so, to uric acid. The possibility of a general membrane transport problem similar to that encountered at
the liver cell has not been confirmed with studies of red cells in the Dalmatian.
This dog shows some similarities to certain rare clinical human diseases with
deafness, cardiac arrhythmias and renal tubule leak of uric acid, all of which
offer ample opportunity for close and detailed examination as clinical models
in biochemical, physiological, pathological and genetic studies.

Uric acid, the end product of purine
metabolism in man, and also the higher
apes, is a highly insoluble and biologically benign material. It introduces a
problem of excretion because its solubility in water at 40°C is only 50 mg
per liter. In urine the solubility is
slightly greater and the concentration
is usuafly near saturation level. The
clinical problems of uric acid stone
formation and obstructive uric acid
nephropathy develop as a consequence
of this limited solubility. Uricosuric
drugs (probenecid, salicylates, sulfinpyrazone, etc.) and more recently allopurinol (an enzyme inhibitor of uric
acid oxidation) for the first time have
successfufly controlled many of these

clinical hazards. However, once a patient has been identified as a former of
uric acid stones, particularly in gouty
arthritis or with primary hyperuricemia,
therapy aimed at correcting these problems has to be continued indefinitely.
Man is not as fortunate as the lower
animals, which are capable of handling
uric acid in a more efficient manner.
Further down the evolutionary scale,
the fish and amphibia excrete most of
the nitrogen of protein metabolism as
urea and ammonia and the mammals
have also maintained this mechanism
as a major means of nitrogen excretion
(Fig 1). However, the reptfles and the
birds developed a very clever waterconserving system whereby the last
phases of breakdown from protein nitrogen to urea were eliminated, and
uric acid is the end-product. This
allowed twice the number of nitrogen
atoms to be excreted per molecule of

'•'Support for these studies was made possible by grants from the Michigan Chapter of the Arthritis Foundation and Henry
Ford Hospital (Grant #437).
• "•'Division of Rheumatology

105

Duncan and Curtiss
available water. In the bird the plasma
uric acid level is simflar to man (3-7
mg/100 ml) and the uric acid is concentrated three-thousand times in the
tubular urine of the bird and secreted
into the cloaca.^ From here, the water
is reabsorbed by the cloacal membrane,
and the uric acid in solution, already
supersatured crystalizes and, with this,
becomes osmotically and finally biologically inactive. The insolubility of
this white uric acid paste can be seen
on the superior aspects of our public
buildings and statues, which have been
visited by pigeons and starlings.
In the dog and similar lower mammals uric acid is effectively oxidized
by the hepatic enzyme uricase, which

converts the insoluble uric acid to the
more soluble allantoin (Fig 1). Man,
however, has not shared this bequest
from aquatic ancestors. Partly because
of these basic metabolic differences
between man and dog, research into
the control of the uric acid problem
has been slow. These biological differences result in man having a serum
uric acid level of around 3-7 mg/100
ml and he excretes some 500-700 mg
of uric acid per day in the urine while
the dog with a plasma uric acid level
of less than 0.3 mg/100 ml has a daily
24-hour urine output of uric acid of
10-60 mg. Consequently, the solubflity
problems for the dog are negligible and
uric acid lithiasis is rare.
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Uric Acid Transport in Man, the Dalmatian and the non-Dalmatian Dog
The purebred Dalmatian (Fig 2) is
distinguished biochemically by its extremely high uric acid output (400-600
mg/24 hours in a 10 kgm dog). The
plasma uric acid level is two to four
times that of the mongrel dog and as a
consequence the Dalmatian* pays the
penalty for his genetic abnormality
with a very high frequency of renal and
bladder stones. During the past four
years we have used allopurinol in the
Dalmatian to control the uric acid
production and reduce the uric acid
output in the same manner as we have
in humans with the same problems.
In this particular breed we recog-

nize its intermediate position, in the
handling of uric acid, with man on the
one hand incapable of oxidizing uric
acid and on the other the non-Dalmatian breeds oxidizing uric acid most
efficiently. For this and other reasons
to be enumerated, this purebred dog
serves us with a remarkable opportunity to study the physiological, biochemical and pharmacological actions
and reactions of uric acid. Even
though this biochemical attribute was
recognized specifically in 1916,- the
amount of such investigation has been
singularly little. Only in recent times
has there been sufficient interest in this
particular breed to bring about the
establishment of the Dalmatian Research Foundation in 1969.**
Aside from the basic uric acid dis-

'•'The reason that the dog has been called
by this name is uncertain. There is no
reason to believe that it derived from
Dalmatia (Yugoslavia) anymore than it
was first bred in England or Bengal although it has often been called an English
Coach Hound and the Bengal Harrier.

"•'Through the efforts of a Dalmatian fancier: J.C. Lowery of York, Pennsylvania.
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deaf Dalmatians, it was noteworthy
that this "syndrome" in the Dalmatians
resembled an unusual clinical picture
also seen in man. In this syndrome,
offspring of cousin marriages developed
combinations of congenital deafness,
pigment patches, bizarre electrocardiograms, renal disease, and sudden
death. To our knowledge, uric acid of
these children is not abnormal.
The deafness in these dogs is reported to be due to V l l l t h nerve damage, but degeneration of the organ of
Corti and coflapse of the cochlear
duct and saccule have been described.''
These defects seem unrelated to the
uric acid abnormality.
Although the full uric acid story is
not yet known, it is clear that in the
Dalmatian at least two distinct abnormalities exist. In the mongrel dog
and in the human, uric acid is filtered
through the glomerulus and approximately 98%-100% of this is reabsorbed by the proximal tubules and
that which ultimately reaches the urine
is thought to be almost entirely secreted
by the distal tubule (Fig 3). In the Dalmatian, there is no resorption of uric
acid at the proximal tubule and a small
amount is secreted by the distal tubule.
Hence in the Dalmatian, the uric acid
clearance may be equal to or even
greater than the creatinine and insulin
clearances in the same animal.^ *
This renal abnormality in the Dalmatian aflows the uric acid to be
rapidly excreted and would tend to
produce the low plasma uric acid level
(0.5-1.0 mg) seen in this dog compared
with that of man as we noted earlier.
The high urine uric acid output from
a 10 kgm dog equals that of a 70 kgm
man. A counterpart appears in human
patients with Wflson's disease or hepa-

turbances, there are other areas of
physiological, pathological, clinical and
genetic significance known to be more
common in this breed than others.
The main biological aberrations in
the Dalmatian include:
(1) Unique urate metabolism in:
a. liver
b. renal clearance
(2) Congenital deafness
(3) Cardiac arrhythmias and arrest
(4) Heterochromia of the iris, china
eye and walleye
(5) Renal calculi, hematuria, pyelonephritis
(6) Pigment "patches"
(7) Recurrent dermatitis
While many of these characteristics
are also seen in other pure-bred dogs
and reflect the result of close inbreeding—the uric acid disturbance is
unique to the purebred Dalmatian. The
high level of uric acid in the urine and
plasma falls dramatically in the offspring of a cross between a pure Dalmatian bred to any other strain. Even
by careful "back breeding" of such
offspring into the original pure strain,
the uric acid abnormality reacts as a
true recessive; even though the characteristic polka-dot pattern of the coat
can be reconstituted, the uric acid abnormality fails to reappear.3 The essence of this study reveals that the
spotting phenomenon of the Dalmatian
and the uric acid abnormality are
coded on different genes.
In 1967, James,* at the Henry Ford
Hospital reviewed the cardiograms of
32 normal and 9 deaf purebred Dalmatians and found a higher incidence of
cardiac arrhythmias in the deaf dogs
compared with the normals in the same
breed. Whereas it is our experience
that the sudden death may occur in
108
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URATE TRANSPORT IN THE KIDNEY
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Figure 3
tolenticular degeneration with a modified deToni Fanconi syndrome wherein
the proximal tubules fafl to resorb uric
acid and the uric acid clearance approaches that of creatinine. In these
young people it is usually noted that
the serum uric acid is in the range of
0.5 to 1.5 mg/100 ml. If the Dalmatian
kidney is capable of excreting 10-100
times more uric acid per day in the
urine than the mongrel dog, why then
is its plasma uric acid level 3-4 times
higlier rather than lower than that of
the mongrel dog? It is important to
understand at the same moment that
there is no evidence that there is increased nitrogen turnover in the Dalmatian compared with the nonDalmatian dog. This being so, some
other aberration in the metabolism of
uric acid must exist in this animal.
It has been shown that in addition

to the renal differences mentioned, the
Dalmatian fails to oxidize uric acid as
efficiently as the mongrel. In all dogs
uric acid is oxidized by the enzyme
uricase which is abundantly present in
the liver including that of the Dalmatian. There is no significant amount of
uricase or other uric acid oxidizing
enzyme in any other tissue.^ Several
studies have shown that the hepatic
oxidation of uric acid in the Dalmatian
differs from that of the non-Dalmatian.
One series of observations^" showed
that when the ureters of the mongrel
dog were clamped, the serum uric acid
level remained low despite the increasing levels of creatinine and other nflrogenous end-products. This was felt to
be due to efficient oxidation of the
excess urate load by hepatic uricase.
In the Dalmatian the serum uric acid
level rose rapidly together with the
109
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serum creatinine and urea when the
same studies were performed. Another
study'^ showed that the liver could be
implicated in the Dalmatian's faflure
to oxidize an excess intravenous load
of uric acid. The evidence was that although the intact kidney excreted 52%
of the intravenous load in 60 minutes,
the plasma uric acid level was stfll six
times the normal figure whereas a
simflar load given to non-Dalmatians
was completely oxidized within 60
minutes—even though only 12% of
the load was recovered in the urine and
the plasma level was normal. These
studies appeared to confirm the premise of Klemperer et aP who in 1938
stated that the Dalmatian liver contained uricase which was quantitatively
capable of oxidizing as much uric acid
as the mongrel dog, but the liver cell
wafl in some way prevented this action.
His evidence depended upon the astute
observations that when liver tissue
from Dalmatian and from nonDalmatian dogs was homogenized and
incubated with uric acid, the rates of
oxidation of uric acid by these homogenates was the same for each group.
However, when intact liver slices were
used in the same type of uric acid
oxidizing system, the slice of nonDalmatian liver was greatly superior
in oxidizing uric acid than the slice
of Dalmatian liver. The inference from
these studies was that the intact hepatic
ceflular membrane prevented the association between uric acid in the
blood and the uricase present in the
hepatic cell.
In recent studies we have shown that
although a constant load of uric acid
is delivered to the Dalmatian liver,
both by hepatic artery and portal vein,
it fails to oxidize the uric acid as effi-

ciendy as the mongrel dog.
Observations: Eight Dalmatians and
six mongrel dogs were anesthetized
and small cannulae were placed in each
of the following sites: (1) abdominal
aorta; (2) renal vein; (3) portal vein;
(4) hepatic vein; (5) jugular vein. After
baseline blood samples were taken
from these sites, a rapid injection of
uric acid (40/mg/kg) was given into
the jugular vein. At intervals of five
minutes after this bolus injection and
for a period of 40 minutes, samples
were drawn simultaneously from each
site cannulated and uric acid levels
were determined on each sample
(Table 1). The arteriovenous urate differences for liver, kidney and gastrointestinal tract were calculated.
From these studies two important
points became evident: (1) The hepatic
"clearance" of uric acid in the mongrel
dog was greater than the Dalmatian
for, in the latter, the arteriovenous
difference was similar for all organs
excepting the kidney. (2) There was
no measurable loss of uric acid into
the gastrointestinal tract in eflher
group. (This fact is rather significant
when it is remembered that in humans
some 200-400 mg of uric acid per 24
hours is secreted into the gastrointestinal tract and is oxidized.) From
this, we deduced that the circulating
uric acid in the Dalmatian is prevented
from being oxidized presumably by
some block in the membrane permeability to uric acid in the Dalmatian
hepatic structure.
If such a problem exists in one
region of the purebred dog, does this
account for the differences in handling
uric acid in the renal tubule and might
it not be present also in some other
more accessible areas such as the red
110
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TABLE I
Mean Values* of Serum Uric Acid (mg/lOOmI)
Determined at Intervals Following l.V.
Injection of 40 mg/kg of Uric Acid
NON-DALMATIAN

DALMATIAN

Time (minutes)
0
5
10
15
20
30
40

Renal Vein

Hepatic Vein

Renal Vein

0.6
8.1
4.1
3.8
3.6
2.9
1.0

0.6
5.8
3.1
2.4
1.8
1.6
0.9

0.4
12.2
10.0
8.3
7.4
5.6
5.0

Hepatic Vein
0.8
15.1
11.1
8.6
7.8
6.8
5.4

* Eight Dalmatians and six mongrel dogs were studied
blood cell or the white blood cefl? In
humans the polymorphonuclear leucocyte is capable of concentrating uric
acid—a situation which is occasionally
seen in gouty patients whose peripheral
circulating polymorphonuclear cells'^
contain one or more large crystals of
uric acid.
Uric acid is also present wflhin human red blood cells and Danish workers have studied the transport of uric
acid across the red cefl membrane.'^•iThey have shown that although physical diffusion of uric acid occurs, an
active transport system—"mediated
transport"—accounted for the majority
of transfer of uric acid from the suspending medium to the red blood cefl.
This urate transport was altered by pH
changes, temperature changes, and
changes in concentrations to which the
Michaelis equation for enzyme reaction
rates could be applied. This enzyme

mediated transport is blocked by the
presence of other purines, i.e., hypoxanthine, and accelerated in the presence of estrogens. We have conducted
such studies on 40 normal adult and
gouty patients in an endeavor to determine the presence of urate transport
abnormalities. No such discrepancy
has been noted.
By using this system on two Dalmatians and "a number" of mongrel dogs,
Harvey and Christensen^^ suggested
that a red cell membrane transport
block existed in the Dalmatian's erythrocytes and not in those of the mongrel
dog. Such a circumstance would help
explain the problem at the hepatic cell
membrane in the Dalmatian but, unfortunately, we have not been able to
confirm these studies even though performed identically and repeatedly on
erythrocytes of 10 purebred Dalmatians and 14 mongrel dogs.
Ill

Duncan and Curtiss
Method
The detafls of the method have been
previously delineated.'Basically the
movement of uric acid across the red
cell membrane is monitored by using
radioactive uric acid (labelled '^C in
the "2"-position). In the steady state
the levels of uric acid within the cell
and in the suspending medium do not
change but a steady influx and efflux
of uric acid molecules is constantly occurring. The influx is measured by the
rate of decline of concentration of labelled uric acid in the suspending
medium during 60 and 120 minutes of
incubation. If hypoxanthine has previously been added to the medium, the
active transport of uric acid is inhibited.
Fresh samples of blood were centrifuged and the red cells separated,
washed, and suspended in a physiological buffer containing a uric acid concentration equal to the previous plasma
level. These cefls (5 ml) were incubated
with 5 ml of buffer at 24°C for 45
minutes to permit a steady state to be
established and then at zero time 0.4
microcuries of uric acid in 0.11 mg of
stable uric acid contained in a 0.2 ml
volume was added. Aliquots were
taken immediately after mixing at zero
time, and at 60 minutes and 120 minutes and at intervals between. The cells
were rapidly centrifuged at 0°C in a
two-minute period and samples 0.2 ml
of the supernatant were transfered to
scintiflation-counting vials. The transfer across the red blood cell membrane
and into the red cell was represented by
the fall of radioactivity of the supernatant fluid and can be cross-checked
subsequently by separation of the red
blood cells then promoting their hemolysis and evaluating the concentra-

tion of intracellular radioactivity separately. While normal physical dfliusion occurs, evidence of the presence
of a mediated transport system is appreciated by the more rapid fall in the
radioactivity of the supernatant fluid.
If hypoxanthine is added to the incubating medium, mediated transport is
stopped and the slow decline in the
radioactivity of the supernatant represents physical diffusion factor alone.
Results
Table 11 shows the percentage of
the radioactive uric acid present at zero
time, 60 minutes, and 120 minutes
foflowing its introduction to the system. Human, Dalmatian and nonDalmatian red cells have been studied.
Included also in the study on the supernatant are figures available for these
changes when hypoxanthine is present
in the suspending medium. In the human the concentration of the labelled
uric acid fefl from 100% at zero time
to 81.9% at 60 minutes and 75.3%
at 120 minutes. When hypoxanthine
was added, the mediated transport system was blocked and the fall of radioactivity at 60 minutes was 89.3% and
at 120 minutes was 84.3% which
represented the slow physical diffusion
factor. In the studies involving the sets
of dogs no evidence of a mediated
transport of uric acid was found for
the studies in the presence and absence
of hypoxanthine were the same and
also the same for each breed. Whereas
a difference is known to exist between
human and canine red cell transport,
Harvey and Christensen stated that a
13% difference between the mediated
and the physical diffusion transport
systems was evident in mongrel dogs
but was not present in Dalmatians. In
112
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TABLE II
Uric Acid Transfer into Red Blood Cells
Percentage Radioactivity Present in Supernatant at
Intervals Following Zero Time. (± Standard Deviation)
Medium

0 Minutes

60 Minutes

120 Minutes

Human
RBC's

Buffer only.
With hypoxanthine.

100
100

81.9 ±3.4
89.3 ±4.0

75.3 ±5.0
84.3 ±4.4

Mongrel
RBC's

Buffer only.
With hypoxanthine.

100
100

92.0 ±2.2
92.9 ±2.0

85.6 ±2.0
86.4 ±2.4

Dalmatian
RBC's

Buffer.
With hypoxanthine.

100
100

92.7 ±2.3
93.4 ±1.6

85.4 ±1.9
87.4 ±2.1

our own studies, no such difference
was demonstrable.
This method of observing the concentrating of labelled purines, by suspended red blood cells, forms the basis
of the present tests used in confirming
the diagnosis of the Lesch-Nyhan syndrome. In this syndrome, a partial or
complete deficiency of the enzyme
hypoxanthin-guanine
phosphoribosyl
transferase presents itself clinically in
chfldren with mental deficiency, neurological abnormality, self-mutilating
tendencies, hyperuricemia, and often
uric acid lithiasis. In this group of patients allopurinol has proven partially
effective in reducing the hazard of uric
acid stone formation.
In the gouty patients and idiopathic
uric acid stone formers, allopurinol has
proven eminently effective. Here,
again, it would naturally follow that
the uric acid stone formation and he-

maturia of Dalmatians should be susceptible to the beneficial effects of allopurinol since nucleoprotein degradation in both man and dog are similar.
Using seven Dalmatians and three
mongrels which received 100 and 200
mg/day of allopurinol, our studies
showed the average uric acid output of
the Dalmatian could be reduced from
580 to 420 mg per 24-hour period—a
27% decrease. We have not conducted
any long term studies on the frequency
of stones in the dog population but one
can deduce that if uric acid load should
be decreased, its associated problems
also should be reduced.
The uric acid problems in man are
beginning to be understood and while
some uric acid studies on the chimpanzee have been recently described^'
which show a very close simflarity to
man, the Dalmatians' abnormaUties are
much more readily accessible and per113
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mit the understanding of uric acid metabolism and membrane transport
problems in man as well as the other
aberrations found in this dog and
other purebreds. A closer attention to
this breed with respect to the study of
biochemistry, physiology, pathology,
and genetics could be productive at a

faster and more economical rate with
mutual benefit to both man and dog.
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